Two-day ‘India Pharma 2026’ concludes with strong call for enhanced funding, infrastructure and speed to drive pharmaceutical innovation

• India Pharma 2026 = 9th edition of the flagship pharma conference of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, co-organised with FICCI and the Indian Pharmaceutical Alliance (IPA).
• Theme: "Discover in India: Leapfrogging Life-Sciences Innovation" — signalling a pivot from generics/vaccines leadership to innovation-led, IP-creating pharma.
• Relevance: GS-III (Indian Economy, Industry, S&T) — pharma is a strategic sector (≈US$50 bn exports, "pharmacy of the world") confronting an innovation gap.